Literature DB >> 10189886

Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma.

S Kubo1, S Nishiguchi, T Shuto, H Tanaka, T Tsukamoto, K Hirohashi, T Ikebe, K Wakasa, T Kuroki, H Kinoshita.   

Abstract

The effect of persistent hepatitis C viremia on the outcome after resection of hepatocellular carcinoma (HCC) was investigated in 59 consecutive patients with a single small HCC (< or = 3.0 cm in diameter). The presence of serum hepatitis C virus (HCV) RNA was evaluated using a reverse transcription polymerase chain reaction method as well as a branched DNA probe method. Clinicopathologic findings were compared between patients with and without viremia and the risk factors for poor outcome were evaluated. Hepatitis C virus (HCV) RNA was not detected in the sera from 7 patients (group 1), but was detected in the sera from the other 52 patients (group 2). Alanine aminotransferase (ALT) activity was significantly higher in group 2 than in group 1. The proportion of patients with active hepatitis was significantly higher in group 2. In group 2, new HCC often developed after the operation and four patients died of liver dysfunction. HCV viremia, high ALT activity, high concentration of total bilirubin, and liver cirrhosis were related to recurrence after the operation. Multivariate analysis indicated that HCV viremia and high ALT activity were independent risk factors for recurrence of HCC. Continuous hepatitis with persistent HCV viremia worsened the outcome after the resection of HCC by causing new development of HCC and deterioration of liver function. In patients with HCV-related HCC, but without HCV viremia, satisfactory results can be expected after liver resection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10189886      PMCID: PMC5926050          DOI: 10.1111/j.1349-7006.1999.tb00729.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  42 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Surgical treatment and prognostic variables of hepatocellular carcinoma in 122 cirrhotics.

Authors:  V Di Carlo; G Ferrari; R Castoldi; S Nadalin; C Marenghi; B Molteni; G Taccagni; M Castrucci
Journal:  Hepatogastroenterology       Date:  1995-07

3.  Recombinant interferon-alpha in inoperable hepatocellular carcinoma: a randomized controlled trial.

Authors:  C L Lai; J Y Lau; P C Wu; H Ngan; H T Chung; S J Mitchell; T J Corbett; A W Chow; H J Lin
Journal:  Hepatology       Date:  1993-03       Impact factor: 17.425

4.  Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C.

Authors:  K Chayama; S Saitoh; Y Arase; K Ikeda; T Matsumoto; Y Sakai; M Kobayashi; M Unakami; T Morinaga; H Kumada
Journal:  Hepatology       Date:  1991-06       Impact factor: 17.425

5.  Risk factors and the effect of interferon therapy in the development of hepatocellular carcinoma: a multivariate analysis in 343 patients.

Authors:  K Kuwana; T Ichida; T Kamimura; S Ohkoshi; N Ogata; T Harada; K Endoh; H Asakura
Journal:  J Gastroenterol Hepatol       Date:  1997-02       Impact factor: 4.029

6.  Can determination of the proliferative capacity of the nontumor portion predict the risk of tumor recurrence in the liver remnant after resection of human hepatocellular carcinoma?

Authors:  J H Chiu; L H Wu; H L Kao; H M Chang; S H Tsay; C C Loong; G Y Chau; W Y Lui
Journal:  Hepatology       Date:  1993-07       Impact factor: 17.425

7.  Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alpha.

Authors:  H Hagiwara; N Hayashi; E Mita; K Ueda; T Takehara; A Kasahara; H Fusamoto; T Kamada
Journal:  Hepatology       Date:  1992-01       Impact factor: 17.425

8.  Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma.

Authors:  K Ikeda; S Saitoh; A Tsubota; Y Arase; K Chayama; H Kumada; G Watanabe; M Tsurumaru
Journal:  Cancer       Date:  1993-01-01       Impact factor: 6.860

9.  Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon.

Authors:  M Shindo; A M Di Bisceglie; J H Hoofnagle
Journal:  Hepatology       Date:  1992-06       Impact factor: 17.425

10.  Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis.

Authors:  S Kubo; S Nishiguchi; K Hirohashi; T Shuto; T Kuroki; S Minamitani; T Ikebe; T Yamamoto; K Wakasa; H Kinoshita
Journal:  Jpn J Cancer Res       Date:  1998-04
View more
  18 in total

1.  Prevention of cancer recurrence after treatment for hepatitis C virus-related hepatocellular carcinoma by interferon therapy.

Authors:  Shoji Kubo
Journal:  Clin J Gastroenterol       Date:  2009-04-08

2.  Effect of previous interferon treatment on outcome after curative treatment for hepatitis C virus-related hepatocellular carcinoma.

Authors:  Hirokazu Miyatake; Yoshiyuki Kobayashi; Yoshiaki Iwasaki; Shin-Ichiro Nakamura; Hideki Ohnishi; Kenji Kuwaki; Junichi Toshimori; Hiroaki Hagihara; Kazuhiro Nouso; Kazuhide Yamamoto
Journal:  Dig Dis Sci       Date:  2011-10-12       Impact factor: 3.199

Review 3.  Adjuvant therapy after curative resection for hepatocellular carcinoma associated with hepatitis virus.

Authors:  Shoji Kubo; Shigekazu Takemura; Chikaharu Sakata; Yorihisa Urata; Takahiro Uenishi
Journal:  Liver Cancer       Date:  2013-01       Impact factor: 11.740

4.  The hippurate ratio as an indicator of functional hepatic reserve for resection of hepatocellular carcinoma in cirrhotic patients.

Authors:  A W Hemming; S Gallinger; P D Greig; M S Cattral; B Langer; B R Taylor; Z Verjee; E Giesbrecht; Y Nakamachi; K N Furuya
Journal:  J Gastrointest Surg       Date:  2001 May-Jun       Impact factor: 3.452

5.  Surgical treatment for hepatocellular carcinoma detected after successful interferon therapy.

Authors:  Shoji Kubo; Hiromu Tanaka; Shigekazu Takemura; Satoshi Yamamoto; Seikan Hai; Tsuyoshi Ichikawa; Shintaro Kodai; Hiroji Shinkawa; Taichi Shuto; Kazuhiro Hirohashi
Journal:  Surg Today       Date:  2007-03-26       Impact factor: 2.549

6.  Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma.

Authors:  Hiroaki Hagihara; Kazuhiro Nouso; Yoshiyuki Kobayashi; Yoshiaki Iwasaki; Shinichiro Nakamura; Kenji Kuwaki; Junichi Toshimori; Hirokazu Miyatake; Hideki Ohnishi; Hidenori Shiraha; Kazuhide Yamamoto
Journal:  Int J Clin Oncol       Date:  2010-12-09       Impact factor: 3.402

7.  Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma.

Authors:  Soocheol Jeong; Hiroshi Aikata; Yoshio Katamura; Takahiro Azakami; Tomokazu Kawaoka; Hiromi Saneto; Kiminori Uka; Nami Mori; Shintaro Takaki; Hideaki Kodama; Koji Waki; Michio Imamura; Hiroo Shirakawa; Yoshiiku Kawakami; Shoichi Takahashi; Kazuaki Chayama
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

8.  Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma.

Authors:  Soo Cheol Jeong; Hiroshi Aikata; Yoshio Katamura; Takahiro Azakami; Tomokazu Kawaoka; Hiromi Saneto; Kiminori Uka; Nami Mori; Shintaro Takaki; Hideaki Kodama; Koji Waki; Michio Imamura; Hiroo Shirakawa; Yoshiiku Kawakami; Shoichi Takahashi; Kazuaki Chayama
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

9.  Pulmonary resection for non-small cell lung cancer in patients with hepatocellular carcinoma.

Authors:  Takashi Iwata; Noritoshi Nishiyama; Koshi Nagano; Nobuhiro Izumi; Shinjiro Mizuguchi; Ryuhei Morita; Takuma Tsukioka; Shoji Hanada; Kiyotoshi Inoue; Shoji Kubo; Shigekazu Takemura; Shigefumi Suehiro
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

10.  Second hepatic resection for recurrent hepatocellular carcinoma in patients with chronic hepatitis C.

Authors:  Shoji Kubo; Shigekazu Takemura; Takahiro Uenishi; Takatsugu Yamamoto; Kazuki Ohba; Masao Ogawa; Seikan Hai; Tsuyoshi Ichikawa; Shintaro Kodai; Hiroji Shinkawa; Hiromu Tanaka
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.